Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Comment by chrispion Oct 19, 2020 12:25pm
107 Views
Post# 31739340

RE:RE:RE:RE:RE:Why is Denali such a big deal?

RE:RE:RE:RE:RE:Why is Denali such a big deal?I'm not saying Denali should not be valued at its current market cap (which is 100+x Bioasis').
I am saying we should be valued higher than our current market cap and that the valuation gap between the two companies shouldn't be as vast as it is. Perhaps the right metric is they are valued at 99x so that still means we are 100% undervalued right now.

I leave it as homework to go thru the various share price/market cap scenarios inbetween.
<< Previous
Bullboard Posts
Next >>